Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Simeox Therapy at Home Versus Standard of Care in NCFB Patients With CMH

NCT: NCT06237348 · COMPLETED

NCT IDNCT06237348

StatusCOMPLETED

Start Date2023-12-01

Completion2024-12-30

SponsorPhysio-Assist (INDUSTRY)

First posted2024-02-01

Last updated2026-08-20

Brief Summary

This pilot RCT will assess benefits of Simeox technology on lung function, respiratory symptoms, health-related quality of life, subjective efficiency, device adherence at home, Patient satisfaction, tolerance, safety, and telecare feasibility.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑